KDDI opens lab to promote innovation through cross-boundary discussion between operators and vendors
TOKYO, February 26, 2020 –IP Infusion, a leading provider of intelligent network software for telecom and data communications services, announced it will be participating in KDDI Corporation's Telecom Infra Project (TIP) Community Lab which will be based in Tokyo. The Tokyo lab joins other labs around the world to create a test center to test related software and hardware on white boxes, and to share knowledge with other industry members.
As its charter, TIP aims to collaborate on building new technologies, examining new business approaches, and spurring investment in the telecom space. By applying the telecom trends, such as open networking and disaggregation, TIP sets a goal to bring innovations to software, hardware and operations based on white box solutions. TIP Community Labs are physical spaces that enable collaboration between member companies in a TIP project group to develop telecom infrastructure solutions.
The TIP Community Labs are dedicated to promoting TIP projects by TIP project teams. The KDDI-sponsored TIP Community Lab joins other Community Lab locations in Berlin, Germany; Menlo Park, California, USA; Northridge, California, USA; Kansas City, Missouri, USA; Louisville, Colorado, USA; Rio de Janeiro, Brazil; Sao Paolo, Brazil; Manesar, India; London, UK; Adastral Park, Ipswich, UK; Turin, Italy and Madrid, Spain.
At the new TIP community lab, TIP member companies will test disaggregated NOS (network operating system) solutions on various hardware designs including DCSG (Disaggregated Cell Site Gateway) technologies.
"We believe that the Community Labs, such as this new one in Tokyo, will make it easier to test and trial White Box solutions, which will help to promote the use of White Box across the industry on a worldwide basis," said Atsushi Ogata, CEO and president of IP Infusion. "With the growing adoption of disaggregated networks, it is vital for the industry to develop a common, standardized platform that will lead to faster deployments, more telecom services and more effective support for all vendors."
Über IP Infusion
IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Pressekontakt
Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779
Über IP Infusion
IP Infusion ist ein führender Anbieter von Open-Networking-Software und liefert OcNOS, ein Carrier-Grade-Netzwerkbetriebssystem für Service Provider, Rechenzentren und AI-Fabric-Netze. Mit 26+ Jahren Netzwerkerfahrung und 600+ Operatoren weltweit ermöglicht IP Infusion offene, herstellerübergreifende, kosteneffiziente und flexible Netzwerkinfrastruktur auf validierter offener Hardware von Partnern wie Edgecore Networks, UfiSpace und Celestica. IP Infusion ist eine hundertprozentige Tochtergesellschaft der ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Pressekontakt
For press inquiries, analyst briefings, or media materials, please unser Team kontaktieren or email pr@ipinfusion.com.
Zukunftsgerichtete Aussagen
Diese Mitteilung kann zukunftsgerichtete Aussagen zu Produkten, Technologien und Plänen von IP Infusion enthalten. Zukunftsgerichtete Aussagen beruhen auf den zum Veröffentlichungsdatum verfügbaren Informationen und sind mit Risiken und Unsicherheiten verbunden. Die tatsächlichen Ergebnisse können abweichen. Produktpläne, Funktionen, Release-Termine und Verfügbarkeit können sich ohne Vorankündigung ändern und stellen keine Zusage, kein Versprechen und keine rechtliche Verpflichtung dar. IP Infusion übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren.